Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro support groups are communities, mostly online, where people using tirzepatide for weight management share experiences, ask questions and encourage each other week to week. They are not medically supervised, but many people find them genuinely useful alongside clinical care. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber must assess your suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It happens within the first week for most people. The pen is in the fridge, the Patient Information Leaflet is on the kitchen table, and somewhere between dinner and bedtime you've joined a Mounjaro UK support group on Facebook with 40,000 members. The questions in there are the ones you couldn't quite phrase to a GP: what does the nausea feel like on day three, does anyone else feel full after six forkfuls, is the fatigue normal?
Peer communities like these are a legitimate part of how people adjust to a new treatment. Members share injection technique, discuss which foods sit well in the early weeks, and offer the kind of solidarity that a three-minute clinical appointment rarely has room for. The experiences shared in UK Mounjaro communities reflect genuine patterns: the GI symptoms that peak in the first fortnight and then ease, the slow shift in appetite that takes a few weeks to become obvious.
What these groups do less well is distinguish between one person's experience and clinical guidance. A forum thread is not the same as a prescriber reading your file. The NHS tirzepatide information page sets out the known side-effect profile clearly; when someone in a group insists their symptom is fine because it happened to them too, that's reassurance, not medical assessment. Keep both in your life.
The honest answer is that Mounjaro support groups in the UK are excellent at three things: normalising the adjustment period, keeping motivation up during a plateau, and flagging questions you hadn't thought to ask your prescriber. They are poor at two things: dosing decisions and sourcing advice.
Titration (when to move from 2.5mg to 5mg, whether to stay on a dose longer) is a clinical call, not a crowd vote. The same applies to anything involving symptoms. Severe, persistent stomach pain that spreads towards the back is listed by the MHRA as a sign to seek urgent medical attention; it is not something to crowdsource. The emotional side effects people sometimes report (low mood, heightened anxiety) also belong in a clinical conversation, not only a comment thread.
The supply question is where groups become actively risky. A well-meaning member posting a link to a cheaper seller, or reassuring others that a product without a GPhC-registered pharmacy behind it is fine, can cause real harm. Genuine UK supply of tirzepatide runs through the licensed supply chain; the MHRA has confirmed that fake tirzepatide pens are being sold online, and if you want a clear picture of how Mounjaro supplies work through a legitimate service, that context helps you spot the red flags in group posts, with around 20 million doses of illegally traded weight-loss medicines seized in 2025 alone. Any seller offering these medicines without a clinical assessment and a valid prescription is a red flag regardless of what the forum says.
The people who get the most from Mounjaro treatment tend to combine peer support with proper clinical backing, not choose between them. Join the Facebook group for the 11pm "is this normal" reassurance. Use your prescriber for anything that involves a decision. And if your current service doesn't include aftercare between doses, on-treatment weight support is worth thinking about before your next pen arrives.
At nume, every repeat order goes back to a GPhC-registered Independent Prescriber for review before it's dispensed. There are no automatic refills; a clinician reads your update each time. Our clinical team is available for aftercare seven days a week, which takes some pressure off the peer group to fill a gap it was never designed to fill.
It's also worth knowing what the peer communities tend to get right about cost: the full picture of Mounjaro treatment in the UK includes prescription, clinical oversight and delivery, not just the pen. Understanding that before you join a group makes you a more sceptical reader of the cheap-supply posts. If you're weighing up your options, a free consultation via our treatment page is the place to start; a prescriber will tell you whether tirzepatide is suitable for you, no obligation.
One practical note: if you order by 12pm on a weekday and your consultation is approved, dispatch goes out the same day. Your group chat will still be there when your pen arrives the next morning.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.